Lens-array PDV probe using a pyramid prism

Author Institution: Los Alamos National LaboratoryAuthor Institution: National Security Technologies, LLCSlides presented at the 6th Annual Photonic Doppler Velocimetry (PDV) Workshop held at Lawrence Livermore National Laboratory, Livermore, California, November 3-4, 2011

PDV Probe Design with Stereo Imaging

Author Institution: National Security Technologies, LLCSlides presented at the 7th Annual Photonic Doppler Velocimetry (PDV) Workshop held at Sandia National Laboratory, Albuquerque, New Mexico, October 22-23, 2012

Historical Perspective on the Evolutionof MPDV Probe Designs

Author Institution: National Security Technologies, LLCSlides presented at the 2016 Photonic Doppler Velocimetry (PDV) unclassified program, Bankhead Theater, Livermore, California, June 7 - 9, 2016. Afternoon program, June 8, 2016

Triature Doppler Velocimeter

Author Institution: Los Alamos National LaboratoryAuthor Institution: National Security Technologies, LLCSlides presented at the 3nd Annual Photonic Doppler Velocimetry (PDV) Conference and Workshop held at Sandia National Laboratories, Albuquerque, New Mexico, September 3-4, 2008

Design, construction, alignment, and calibration of a compact velocimetry experiment

A velocimetry experiment has been designed to measure shock properties for small, cylindrical, metal targets (8 mm diameter × 2 mm thick). A target is accelerated by high explosives, caught, then retrieved for later inspection. The target is expected to move at a velocity of 0.1 to 3 km/sec. The complete experiment canister is ~105 mm in diameter and 380 mm long. Optical velocimetry diagnostics include the Velocity Interferometer System for Any Reflector (VISAR) and photon Doppler velocimetry (PDV). The packaging of the velocity diagnostics is not allowed to interfere with the foam catchment or an X-ray imaging diagnostic. Using commercial lenses, a single optical relay collects Doppler-shifted light for both VISAR and PDV. The use of fiber optics allows measurement of point velocities on the target surface for accelerations lasting for 3 mm of travel. Operating at 532 nm, the VISAR has separate illumination fibers requiring alignment. The PDV diagnostic operates at 1550 nm but is aligned and calibrated at 670 nm. VISAR and PDV diagnostics are complimentary measurements that image spots in close proximity on the target surface. Because the optical relay uses commercial glass, optical fibers’ axial positions are offset to compensate for chromatic aberrations. The optomechanical design requires careful attention to fiber management, mechanical assembly and disassembly, foam catchment design, and X-ray diagnostic field of view.Calibration and alignment data are archived at each assembly sequence stage. The photon budgets for the VISAR and PDV diagnostics are separately estimated

AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions

Chronic cancer pain is a serious complication of malignancy or its treatment. Currently, no comprehensive, universally accepted cancer pain classification system exists. Clarity in classification of common cancer pain syndromes would improve clinical assessment and management. Moreover, an evidence-based taxonomy would enhance cancer pain research efforts by providing consistent diagnostic criteria, ensuring comparability across clinical trials. As part of a collaborative effort between the Analgesic, Anesthetic, and Addiction Clinical Trial Translations Innovations Opportunities and Networks (ACTTION) and the American Pain Society (APS), the ACTTION-APS Pain Taxonomy (AAPT) initiative worked to develop the characteristics of an optimal diagnostic system.59, 65 Following the establishment of these characteristics, a working group consisting of clinicians and clinical and basic scientists with expertise in cancer and cancer-related pain was convened to generate core diagnostic criteria for an illustrative sample of 3 chronic pain syndromes associated with cancer (i.e., bone pain and pancreatic cancer pain as models of pain related to a tumor) or its treatment (i.e., chemotherapy-induced peripheral neuropathy). A systematic review and synthesis was conducted to provide evidence for the dimensions that comprise this cancer pain taxonomy. Future efforts will subject these diagnostic categories and criteria to systematic empirical evaluation of their feasibility, reliability and validity and extension to other cancer-related pain syndromes

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat